Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

A Multi-center, Prospective, Registry Study to Analyze the Clinical Characteristics and Prognosis of Different Molecular Subtypes of Peripheral T-cell Lymphoma.

NCT07657572

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

NCT07607925

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: GSK Investigational Site Canton, Ohio, United States

GSK Investigational Site Toronto, Ontario, Canada

GSK Investigational Site Tokyo, Japan

View Trial Details

Not Yet Recruiting

Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma

NCT07654465

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Sun yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

HEME-25: Open-Label Feasibility Study of Elranatamab Utilized in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV

NCT07647432

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +26 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Research for Resistance Factors in the Treatment of Lymphoid Hemopathy

NCT07385612

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: CHD Vendée La Roche-sur-Yon, France

CHU Nantes Nantes, France

CHU de Poitiers Poitiers, France

CH de Saint-Nazaire Saint-Nazaire, France

View Trial Details

Not Yet Recruiting

PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma

NCT07641010

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Xuzhou Children's Hospital Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

NCT07335328

Conditions: B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Not Yet Recruiting

SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS

NCT07575412

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Azacytidine, +17 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Axatilimab + CAR-T for High-Risk Lymphoma

NCT07638982

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Digestive System Diseases, Follicular Grade 3 Lymphoma, +21 more
Locations: Northside Hospital Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

NCT07637929

Conditions: Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +19 more
Locations: Not specified

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions